Chronic Intestinal Pseudo-Obstruction: Clinical Features, Diagnosis, and Therapy

Gastroenterology Clinics of North America

Volumn 40, Issue 4, 2011, Pages 787-807

  De Giorgio, Roberto ^a,b   Cogliandro, Rosanna F ^a,b   Barbara, Giovanni ^a,b   Corinaldesi, Roberto ^a,b   Stanghellini, Vincenzo ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Abdominal radiology; Chronic intestinal pseudo obstruction; Diagnosis of severe gut dysmotility; Enteric myopathies; Enteric neuropathies; Intestinal manometry

Indexed keywords

CISAPRIDE; ERYTHROMYCIN; OCTREOTIDE; PLACEBO;

BLADDER DYSFUNCTION; CHRONIC DISEASE; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG RESPONSE; ENTERIC FEEDING; GASTROINTESTINAL ENDOSCOPY; GENETIC ASSOCIATION; GRAFT FAILURE; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; INTESTINAL DYSMOTILITY; INTESTINE BYPASS; INTESTINE PSEUDOOBSTRUCTION; INTESTINE TRANSPLANTATION; LABORATORY TEST; MALNUTRITION; MANOMETRY; PATHOGENESIS; REVIEW; STOMACH PARESIS; TREATMENT OUTCOME; PATHOLOGY;

CHRONIC DISEASE; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION;

EID: 81455143660     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2011.09.005     Document Type: Review

References (73)

1. Dudley H.A.F., Sinclair I.S.R., McLaren I.F., et al. Intestinal pseudo-obstruction. J R Coll Surg Edin 1958, 3:206-217.
2. Naish J.M., Capper W.M., Brown N.J. Intestinal pseudo-obstruction with steatorrhoea. Gut 1960, 1:62-66.
3. Stephens F.O. The syndrome of intestinal pseudo-obstruction. Br J Med 1962, 1:1248-1250.
4. Legge D.A., Wollaeger E.E., Carlson H.C. Intestinal pseudo-obstruction in systemic amyloidosis. Gut 1970, 11:764-767.
5. Stanghellini V., Corinaldesi R., Barbara L. Pseudo-obstruction syndromes. Baillieres Clin Gastroenterol 1988, 2:225-254.
6. Di Lorenzo C. Pseudo-obstruction: current approaches. Gastroenterology 1999, 116:980-987.
7. De Giorgio R., Knowles C.H. Acute colonic pseudo-obstruction. Br J Surg 2009, 96:229-239.
8. Stanghellini V., Camilleri M., Malagelada J.R. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987, 28:5-12.
9. Stanghellini V., Cogliandro R.F., De Giorgio R., et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroent Hepatol 2005, 3:449-458.
10. Stanghellini V., Cogliandro R.F., De Giorgio R., et al. Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil 2007, 19:440-452.
11. Amiot A., Joly F., Alves A., et al. Long-term outcome of chronic intestinal pseudo-obstruction adult patients requiring home parenteral nutrition. Am J Gastroenterol 2009, 104:1262-1270.
12. Lindberg G., Iwarzon M., Tornblom H. Clinical features and long-term survival in chronic intestinal pseudo-obstruction and enteric dysmotility. Scand J Gastroenterol 2009, 44:692-699.
13. De Giorgio R., Stanghellini V., Barbara G., et al. Primary enteric neuropathies underlying gastrointestinal motor dysfunctions. Scand J Gastroenterol 2000, 35:114-122.
14. De Giorgio R., Sarnelli G., Corinaldesi R., et al. Advance in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut 2004, 53:1549-1552.
15. De Giorgio R., Ricciardiello L., Naponelli V., et al. Chronic intestinal pseudo-obstruction related to viral infections. Transplant Proc 2010, 42:9-14.
16. Stanghellini V., Corinaldesi R., Ghidini C., et al. Reversibility of gastrointestinal motor abnormalities in chronic intestinal pseudo-obstruction. Hepatogastroenterology 1992, 39:34-38.
17. De Giorgio R., Seri M., Cogliandro R., et al. Analysis of candidate genes for intrinsic neuropathy in a family with chronic idiopathic intestinal pseudo-obstruction. Clin Gen 2001, 59:131-133.
18. Pingault V., Guiochon-Mantel A., Bondurand N., et al. Peripheral neuropathy with hypomyelination, chronic intestinal pseudo-obstruction and deafness: a developmental "neural crest syndrome" related to a SOX10 mutation. Ann Neurol 2000, 48:671-676.
19. Pingault V., Girard M., Bondurand N., et al. SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism. Hum Genet 2002, 111:198-206.
20. Mungan Z., Akyüz F., Bugra Z., et al. Familial visceral myopathy with pseudo-obstruction, megaduodenum, Barrett's esophagus, and cardiac abnormalities. Am J Gastroenterol 2003, 98:2556-2560.
21. Deglincerti A., De Giorgio R., Cefle K., et al. A novel locus for syndromic chronic idiopathic intestinal pseudo-obstruction maps to chromosome 8q23-q24. Eur J Hum Genet 2007, 15:889-897.
22. Bardosi A., Creutzfeldt W., DiMauro S., et al. Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol 1987, 74:248-258.
23. Nishino I., Spinazzola A., Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999, 283(5402):689-692.
24. Van Goethem G., Schwartz M., Lofgren A., et al. Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy. Eur J Hum Genet 2003, 11:547-549.
25. Giordano C., Sebastiani M., De Giorgio R., et al. Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion. Am J Pathol 2008, 173:1120-1128.
26. Gargiulo A., Auricchio R., Barone M.V., et al. Filamin A is mutated in X-linked chronic idiopathic intestinal pseudo-obstruction with central nervous system involvement. Am J Hum Genet 2007, 80:751-758.
27. Clayton-Smith J., Walters S., Hobson E., et al. Xq28 duplication presenting with intestinal and bladder dysfunction and a distinctive facial appearance. Eur J Hum Genet 2009, 17:434-443.
28. Kapur R.P., Robertson S.P., Hannibal M.C., et al. Diffuse abnormal layering of small intestinal smooth muscle is present in patients with FLNA mutations and X-linked intestinal pseudo-obstruction. Am J Surg Pathol 2010, 34:1528-1543.
29. De Giorgio R., Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil 2004, 16:515-531.
30. Knowles C.H., De Giorgio R., Kapur R.P., et al. The London Classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut 2010, 59:882-887.
31. De Giorgio, Guerrini S., Barbara G., et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology 2004, 126:1872-1883.
32. Knowles C.H., Silk D.B., Darzi A., et al. Deranged smooth muscle alpha-actin as a biomarker of intestinal pseudo-obstruction: a controlled multinational case series. Gut 2004, 53:1583-1589.
33. Lindberg G., Törnblom H., Iwarzon M., et al. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility. Gut 2009, 58:1084-1090.
34. Veress B., Nyberg B., Törnblom H., et al. Intestinal lymphocytic epithelioganglionitis: a unique combination of inflammation in bowel dysmotility: a histopathological and immunohistochemical analysis of 28 cases. Histopathology 2009, 54:539-549.
35. Knowles C.H., De Giorgio R., Kapur R.P., et al. Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol 2009, 118:271-301.
36. De Giorgio R., Barbara G., Stanghellini V., et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 2002, 97:2454-2459.
37. De Giorgio R., Bovara M., Barbara G., et al. Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. Gastroenterology 2003, 125:70-79.
38. Hubball A., Martin J.E., Lang B., et al. The role of humoral autoimmunity in gastrointestinal neuromuscular diseases. Prog Neurobiol 2009, 87:10-20.
39. Di Nardo G., Blandizzi C., Volta U., et al. Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther 2008, 28:25-42.
40. Schäppi M.G., Smith V.V., Milla P.J., et al. Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction. Gut 2003, 52:752-755.
41. Accarino A., Colucci R., Barbara G., et al. Mast cell neuromuscular involvement in patients with severe gastrointestinal dysmotility (SGID). Gut 2007, 56(Suppl III):A18.
42. Mann S.D., Debinski H.S., Kamm M.A. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997, 41:675-681.
43. Bassotti G, Villanacci V. Can "functional" constipation be considered as a form of enteric neuro-gliopathy? Glia 201;59:345-50.
44. Oton E., Moreira V., Redondo C., et al. Chronic intestinal pseudoobstruction due to lymphocytic leiomyositis: is there a place for immunomodulatory therapy?. Gut 2005, 54:1343-1344.
45. Dewit S., de Hertogh G., Geboes K., et al. Chronic intestinal pseudo-obstruction caused by an intestinal inflammatory myopathy: case report and review of the literature. Neurogastroenterol Motil 2008, 20:343-348.
46. Smith J.A., Hauser S.C., Madara J.L. Hollow visceral myopathy: a light- and electronmicroscopic study. Am J Surg Pathol 1982, 6:269-275.
47. Schuffler M.D. Chronic intestinal pseudo-obstruction syndromes. Med Clin North Am 1981, 65:1331-1358.
48. Wedel T., Van Eys G.J., Waltregny D., et al. Novel smooth muscle markers reveal abnormalities of the intestinal musculature in severe colorectal motility disorders. Neurogastroenterol Motil 2006, 18:526-538.
49. Farrugia G. Interstitial cells of Cajal in health and disease. Neurogastroenterol Motil 2008, 20(Suppl 1):54-63.
50. Cogliandro R.F., Antonucci A., De Giorgio R., et al. Patient-reported outcomes and gut dysmotility in functional gastrointestinal disorders. Neurogastroenterol Motil 2011, in press.
51. Lyford G., Foxx-Orenstein A. Chronic intestinal pseudo-obstruction. Curr Treat Options Gastroenterol 2004, 7:317-325.
52. Lara M.C., Valentino M.L., Torres-Torronteras J., et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches. Biosci Rep 2007, 27:151-163.
53. Merlin A., Soyer P., Boudiaf M., et al. Chronic intestinal pseudo-obstruction in adult patients: multidetector row helical CT features. Eur Radiol 2008, 18:1587-1595.
54. Sumiyama K., Gostout C.J. Clinical applications of submucosal endoscopy. Curr Opin Gastroenterol 2011, 27:412-417.
55. Kellow J.E. Small intestine: normal functionclinical disorders. Manometry. Schuster atlas of gastrointestinal motility in health and disease 2002, 219-236. BC Decker, Hamilton-London. M.M. Schuster, M.D. Crowell, K.L. Koch (Eds.).
56. Knowles C.H., Veress B., Kapur R.P., et al. Quantitation of cellular components of the enteric nervous system in the normal human gastrointestinal tract-report on behalf of the Gastro 2009 International Working Group. Neurogastroenterol Motil 2011, 23:115-124.
57. Knowles C.H., Veress B., Tornblom H., et al. Safety and diagnostic yield of laparoscopically assisted full-thickness bowel biospy. Neurogastroenterol Motil 2008, 20:774-779.
58. Derkinderen P., Rouaud T., Lebouvier T., et al. Parkinson's disease: the enteric nervous system spills its guts. Neurology 2011, in press.
59. Pironi L., Spinucci G., Paganelli F., et al. Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure. Transplant Proc 2004, 36:659-661.
60. Camilleri M., Malagelada J.R., Abell T.L., et al. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudo-obstruction. Gastroenterology 1989, 96:704-712.
61. Abell T.L., Camilleri M., DiMagno E.P., et al. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 1991, 36:616-620.
62. Soudah H.C., Hasler W.L., Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991, 325:1461-1467.
63. Camilleri M., Balm R.K., Zinsmeister A.R. Determinant of response to a prokinetic agent in neuropathic chronic intestinal motility disorders. Gastroenterology 1994, 106:916-923.
64. Verne G.N., Eaker E.Y., Hardy E., et al. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 1995, 40:1892-1901.
65. Camilleri M., Balm R.K., Zinsmeister A.R. Symptomatic improvement with one-year cisapride treatment in neuropathic chronic dysmotility. Aliment Pharmacol Ther 1996, 10:403-409.
66. Emmanuel A.V., Shand A.G., Kamm M.A. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004, 19:687-694.
67. Sanger G.J. Translating 5-HT receptor pharmacology. Neurogastroenterol Motil 2009, 21:1235-1238.
68. Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs 2009, 18:349-358.
69. Murr M.M., Sarr M.G., Camilleri M. The surgeon's role in the treatment of chronic intestinal pseudo-obstruction. Am J Gastroent 1995, 90:2147-2151.
70. Lapointe R. Chronic idiopathic intestinal pseudo-obstruction treated by near total small bowel resection: a 20-year experience. J Gastrointest Surg 2010 Dec, 14(12):193742.
71. Pitt H.A., Gomes A.S., Lois J.F., et al. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?. Ann Surg 1985, 201:545-553.
72. Masetti M., Di Benedetto F., Cautero N., et al. Intestinal transplantation for chronic intestinal pseudo-obstruction in adult patients. Am J Transplantation 2004, 4:826-829.
73. Tzakis A.G., Kato T., Levi D.M., et al. 100 multivisceral transplants at a single center. Ann Surg 2005, 242:480-493.